Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,077 | 156 | 72.0% |
| Travel and Lodging | $1,585 | 6 | 28.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,458 | 11 | $0 (2024) |
| HEARTFLOW, INC. | $888.55 | 7 | $0 (2024) |
| ABIOMED | $467.05 | 5 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $463.67 | 26 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $459.65 | 17 | $0 (2024) |
| Boston Scientific Corporation | $327.31 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $224.55 | 18 | $0 (2024) |
| PFIZER INC. | $199.93 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $161.99 | 8 | $0 (2022) |
| Lexicon Pharmaceuticals, Inc. | $128.66 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,433 | 53 | Medtronic, Inc. ($1,375) |
| 2023 | $1,803 | 48 | HeartFlow, Inc. ($870.69) |
| 2022 | $722.27 | 41 | Novartis Pharmaceuticals Corporation ($180.26) |
| 2021 | $488.52 | 13 | ABIOMED ($332.61) |
| 2020 | $166.49 | 6 | E.R. Squibb & Sons, L.L.C. ($80.85) |
| 2019 | $48.53 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($48.53) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Cardiology | ||||||
| 11/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: General - Structural Heart_IC | ||||||
| 11/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $90.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/14/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: CARDIOLOGY | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.44 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.09 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: Not Applicable | ||||||
| 10/31/2024 | Abbott Laboratories | NA (Device) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Electrophysiology | ||||||
| 10/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.01 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $10.48 | General |
| Category: Cardiovascular | ||||||
| 10/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.73 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/04/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/11/2024 | Medtronic, Inc. | VENASEAL (Device) | Travel and Lodging | In-kind items and services | $295.85 | General |
| Category: EndoVenous Therapies | ||||||
| 09/11/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $202.72 | General |
| Category: EndoVenous Therapies | ||||||
| 09/11/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $107.89 | General |
| Category: EndoVenous Therapies | ||||||
| 09/11/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $99.14 | General |
| Category: EndoVenous Therapies | ||||||
| 09/11/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $68.52 | General |
| Category: EndoVenous Therapies | ||||||
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $12.23 | General |
| Category: Cardiovascular | ||||||
| 08/13/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Neurology | ||||||
| 08/09/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $19.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | Medtronic, Inc. | VENASEAL (Device) | Travel and Lodging | In-kind items and services | $546.27 | General |
| Category: EndoVenous Therapies | ||||||
| 08/08/2024 | Medtronic, Inc. | VENASEAL (Device) | Travel and Lodging | In-kind items and services | $55.00 | General |
| Category: EndoVenous Therapies | ||||||
| 08/02/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: DEVICES | ||||||
| 07/31/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: General - Therapies_CRM | ||||||
| 07/02/2024 | Elutia, Inc. | ECM Patch,Pouch (Device) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Cardiovascular Medical Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,042 | 1,329 | $472,455 | $101,368 |
| 2022 | 22 | 877 | 1,088 | $362,510 | $81,305 |
| 2021 | 21 | 697 | 814 | $306,975 | $64,299 |
| 2020 | 4 | 108 | 168 | $48,195 | $10,091 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 259 | $50,505 | $22,620 | 44.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 91 | 91 | $54,145 | $11,777 | 21.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 73 | 77 | $28,490 | $10,096 | 35.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 30 | 30 | $27,450 | $9,407 | 34.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 158 | 162 | $96,390 | $8,308 | 8.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 121 | $16,335 | $7,233 | 44.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 30 | 60 | $20,400 | $5,384 | 26.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 57 | $10,830 | $5,127 | 47.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 19 | 19 | $41,135 | $4,025 | 9.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 35 | 37 | $10,360 | $2,966 | 28.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 17 | 68 | $34,000 | $2,677 | 7.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 20 | $5,000 | $1,962 | 39.2% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 11 | 11 | $5,445 | $1,855 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,100 | $1,825 | 35.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 25 | 25 | $22,875 | $1,452 | 6.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 30 | 30 | $10,500 | $1,342 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $2,160 | $943.04 | 43.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 41 | 48 | $3,600 | $478.50 | 13.3% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 31 | 32 | $5,600 | $432.64 | 7.7% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 22 | 22 | $1,540 | $413.91 | 26.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 28 | 28 | $1,680 | $298.20 | 17.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 13 | 15 | $3,750 | $283.80 | 7.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 29 | 29 | $3,045 | $267.67 | 8.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 38 | 43 | $10,320 | $101.91 | 1.0% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 12 | 12 | $1,800 | $94.27 | 5.2% |
About Manar Jbara
Manar Jbara is a Cardiovascular Disease healthcare provider based in Johnson City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2014. The National Provider Identifier (NPI) number assigned to this provider is 1912325242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Manar Jbara has received a total of $5,662 in payments from pharmaceutical and medical device companies, with $2,433 received in 2024. These payments were reported across 162 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,077).
As a Medicare-enrolled provider, Jbara has provided services to 2,724 Medicare beneficiaries, totaling 3,399 services with total Medicare billing of $257,063. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Student in an Organized Health Care Education/Training Program, Internal Medicine
- Location Johnson City, TN
- Active Since 04/03/2014
- Last Updated 01/28/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1912325242
Products in Payments
- VENASEAL (Device) $1,375
- FFRct (Device) $888.55
- Impella (Device) $467.05
- LifeVest (Device) $463.67
- CAMZYOS (Drug) $237.84
- VYNDAQEL (Drug) $199.93
- JARDIANCE (Drug) $161.99
- LEQVIO (Drug) $149.69
- WATCHMAN Access System (Device) $135.40
- ECM Patch,Pouch (Device) $128.68
- ELIQUIS (Drug) $100.39
- Repatha (Biological) $87.27
- DEFINITY (Drug) $80.91
- Arcalyst (Drug) $77.59
- ENTRESTO (Drug) $74.86
- INJECTAFER (Drug) $53.50
- WATCHMAN FLX (Device) $53.40
- Azure (Device) $47.19
- CARDIVA VASCADE MVP VVCS 6-12F (Device) $46.93
- FUROSCIX (Drug) $45.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Johnson City
Hisham Kashou, Md, MD
Cardiovascular Disease — Payments: $117,995
Dr. Tariq Haddadin, M.d, M.D
Cardiovascular Disease — Payments: $29,701
Owais Ahmed, Md, MD
Cardiovascular Disease — Payments: $28,178
Vipulkumar Brahmbhatt, Md, MD
Cardiovascular Disease — Payments: $19,633
Afzal Rehman, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $14,540
Julius Gasso, Md, MD
Cardiovascular Disease — Payments: $11,205